Monoclonal Antibodies Stocks List Ranked for 2024

Symbol	Grade	Name	% Change
IMNM	F	Immunome, Inc.	0.96
ADCT	F	ADC Therapeutics SA	-2.02
BCAB	F	BioAtla, Inc.	-6.08
CGEN	F	Compugen Ltd.	1.40
SLRN	F	Acelyrin Inc.	-2.26
OABI	F	OmniAb, Inc.	-1.28
IMVT	F	Immunovant, Inc.	1.41
APGE	F	Apogee Therapeutics, Inc.	-4.84
HALO	F	Halozyme Therapeutics, Inc.	-0.13
RCUS	F	Arcus Biosciences, Inc.	-2.33

Symbol	Grade	Name	Weight
CNCR	F	Loncar Cancer Immunotherapy ETF	6.77
IDNA	D	iShares Genomics Immunology and Healthcare ETF	6.18
KURE	D	KraneShares MSCI All China Health Care Index ETF	6.12
CANC	D	Tema Oncology ETF	5.78
IBBQ	D	Invesco Nasdaq Biotechnology ETF	5.24

Compare ETFs

Date	Stock	Title
Nov 21	IMVT	Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?
Nov 20	HALO	Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
Nov 19	RCUS	Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Nov 19	HALO	3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
Nov 19	HALO	HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
Nov 19	HALO	Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?
Nov 19	HALO	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
Nov 18	APGE	Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
Nov 18	HALO	Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
Nov 17	HALO	Halozyme plans to finance $2.1B takeover of Evotech in cash: report
Nov 17	HALO	Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
Nov 15	HALO	Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer
Nov 15	HALO	Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
Nov 15	HALO	Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
Nov 15	IMNM	Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 15	HALO	Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
Nov 15	CGEN	Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Monoclonal Antibodies: Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.